ACRIVON THERAPEUTICS INC (ACRV) Top Institutional Shareholders

ACRIVON THERAPEUTICS INC (ACRV) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $21.12M in ACRV holdings during the latest filing period.

Ra Capital Management, L.P. is currently the largest disclosed institutional shareholder of ACRV tracked by InsiderSet, reporting ownership valued at approximately $11.59M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $12.68M, representing an estimated gain of +9.35% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 95% of the total disclosed ACRV value among the investors covered in this analysis. Major shareholders include Ra Capital Management, L.P., Sands Capital Alternatives, Llc, Wellington Management Group Llp, and several other long-term asset managers with concentrated positions in ACRIVON THERAPEUTICS INC (ACRV).

This page ranks the largest institutional ACRV shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

42

Total Reported Value

$21.12M

Largest Holder

Ra Capital Management, L.P.

Largest Position

$11.59M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

58

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Ra Capital Management, L.P.0.12%8,340,508$11,593,306$12,677,572+$1,084,266+9.35%
Sands Capital Alternatives, Llc0.70%2,122,605$2,950,421$3,226,360+$275,939+9.35%
Wellington Management Group Llp0.00%888,130$1,234,501$1,349,958+$115,457+9.35%
Renaissance Technologies LLCJim Simons0.00%758,440$1,054,232$1,152,829+$98,597+9.35%
Vanguard Capital Management Llc0.00%722,035$1,003,629$1,097,493+$93,864+9.35%
Marshall Wace, Llp0.00%560,436$779,007$851,863+$72,856+9.35%
Two Sigma Investments, Lp0.00%389,395$541,259$591,880+$50,621+9.35%
Jane Street Group, Llc0.00%239,691$333,171$364,330+$31,159+9.35%
Geode Capital Management, Llc0.00%236,391$328,689$359,314+$30,625+9.32%
Blackrock, Inc.0.00%208,939$290,425$317,587+$27,162+9.35%
Bridgeway Capital Management, Llc0.00%158,900$220,871$241,528+$20,657+9.35%
Vanguard Fiduciary Trust Co0.00%107,529$149,465$163,444+$13,979+9.35%
State Street Corp0.00%67,145$93,332$102,060+$8,728+9.35%
Xtx Topco Ltd0.00%66,882$92,966$101,661+$8,695+9.35%
Northern Trust Corp0.00%48,902$67,973$74,331+$6,358+9.35%
Morgan Stanley0.00%36,671$50,973$55,740+$4,767+9.35%
Ubs Group Ag0.00%34,634$48,141$52,644+$4,503+9.35%
Panagora Asset Management Inc0.00%33,814$47,001$51,397+$4,396+9.35%
Squarepoint Ops Llc0.00%27,472$38,186$41,757+$3,571+9.35%
Prelude Capital Management, Llc0.00%24,015$33,381$36,503+$3,122+9.35%
Dimensional Fund Advisors Lp0.00%18,364$25,356$27,913+$2,557+10.09%
Bank Of America Corp0.00%16,513$22,953$25,100+$2,147+9.35%
Goldman Sachs Group Inc0.00%14,742$20,491$22,408+$1,917+9.35%
Two Sigma Securities, Llc0.00%11,679$16,234$17,752+$1,518+9.35%
Aaf Wealth Management, Llc0.01%10,678$14,843$16,231+$1,388+9.35%
Marex Group Plc0.00%10,000$13,900$15,200+$1,300+9.35%
Fmr Llc0.00%9,422$13,097$14,321+$1,224+9.35%
Federated Hermes, Inc.0.00%7,924$11,014$12,044+$1,030+9.36%
Barclays Plc0.00%5,940$8,256$9,029+$773+9.36%
Tower Research Capital Llc (Trc)0.00%4,526$6,291$6,880+$589+9.35%
Vanguard Global Advisers, Llc0.00%4,453$6,190$6,769+$579+9.35%
Wells Fargo & Company/Mn0.00%3,000$4,170$4,560+$390+9.35%
Acadian Asset Management Llc0.00%845,973$1,175$1,285,879+$1,284,704+109336.51%
Bnp Paribas Financial Markets0.00%634$881$964+$83+9.38%
Nisa Investment Advisors, Llc0.00%584$812$888+$76+9.32%
Redwood Park Advisors Llc0.00%500$695$760+$65+9.35%
Russell Investments Group, Ltd.0.00%481$669$731+$62+9.29%
Federation Des Caisses Desjardins Du Quebec0.00%400$556$608+$52+9.35%
Steward Partners Investment Advisory, Llc0.00%326$453$496+$43+9.39%
Gsa Capital Partners Llp0.02%186,716$260$283,808+$283,548+109057.05%
Sbi Securities Co., Ltd.0.00%74$103$112+$9+9.20%
Caitong International Asset Management Co., Ltd0.00%4$6$6+$0+1.33%

Frequently asked questions about ACRV

  • Who owns the most ACRV stock?

    The largest holders of ACRV are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ACRIVON THERAPEUTICS INC (ACRV).

  • Is ACRV widely held by superinvestors?

    Many widely followed stocks like ACRV appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ACRV is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.